Sign inJoin waitlistJoin the waitlist

Damian Green

Translational Science Lead · University of Miami/Jackson Health System

Credentials: · · · · ·

History

Division of Transplantation and Cellular Therapy · University of Miami/Jackson Health System
Present
University of Miami/Jackson Health System
Present

Medical Oncology
2003–2005
Internal Medicine
2000–2003
Ohio State University College of Medicine
1996–2000

Research

Diagnosis and Management of Multiple Myeloma: A Review
Review · JAMA · 2022 · 854 citations
Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma
Annals of Oncology · 1998 · 449 citations
γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma
Blood · 2019 · 294 citations

Ajay Gopal
56 papers
JP
John Pagel
35 papers
David Maloney
34 papers
AC
Andrew Cowan
33 papers · 1 as a fellow
Brian Till
31 papers
Leona Holmberg
28 papers
Johnnie Orozco
26 papers · 2 as a fellow
Brenda Sandmaier
21 papers
David Coffey
19 papers
EL
Edward Libby
19 papers
Ryan Cassaday
18 papers · 1 as a fellow
WB
William Bensinger
17 papers

Grants

Radioimmunotherapy Combinations for B-Cell Malignancy
National Cancer Institute · R01
Contact PI · $3.2M · University of Miami School of Medicine
1998–2027
Preventing Relapse After Non-Myeloablative Stem Cell Transplantation: The Final Challenge
National Cancer Institute · P01
Project lead · $1.8M · Fred Hutchinson Cancer Center
1999–2027
Anti-CD38 Targeted Alpha Emitter Radioimmunotherapy to Eliminate Multiple Myeloma
National Cancer Institute · R01
Contact PI · $2.8M · Fred Hutchinson Cancer Center
2017–2024
Adult Leukemia Research Center
National Cancer Institute · P01
Project lead · $4.5M · Fred Hutchinson Cancer Center
1997–2024

Clinical trials

Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma
Principal investigator · Withdrawn · Phase 1
Fred Hutchinson Cancer Center
2024–2027
Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma
Principal investigator · Completed · Phase 1
Fred Hutchinson Cancer Center
2017–2022
90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma
Principal investigator · Completed · Phase 1
Fred Hutchinson Cancer Center
2012–2019